Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-theranos-elizabeth-holmes2.jpg" NAME"Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued" ALT"Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued"March 24, 2017By Alex Keown,…

Continue ReadingTheranos CEO Gives Up Own Shares to Investors to Avoid Being Sued

Rumor Alert: Sanofi Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-Sanofi-Olivier-Brandicourt.jpg" NAME"Rumor Alert: Sanofi Close to Scooping Up This Massachusetts Biotech in $1 Billion Deal" ALT"Rumor Alert: Sanofi Close to Scooping Up This Massachusetts Biotech in $1 Billion Deal"March…

Continue ReadingRumor Alert: Sanofi Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal

Bay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Bay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test" ALT"Bay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test"March 23, 2017By Alex Keown, BioSpace.com Breaking…

Continue ReadingBay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test

Turns Out Editas Medicine's R&D Deal With Allergan Could be Worth $1 Billion

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal.jpg" NAME"Turns Out Editas Medicine's R&D Deal With Allergan Could be Worth $1 Billion" ALT"Turns Out Editas Medicine's R&D Deal With Allergan Could be Worth $1 Billion"March 23, 2017By…

Continue ReadingTurns Out Editas Medicine's R&D Deal With Allergan Could be Worth $1 Billion